I am an Imperial College Research Fellow at the MRC Centre for Global Infectious Disease Analysis. I work on mathematical models of infectious diseases, focussed on childhood diseases and the public health impact of new vaccines.
The main focus of my current research is to develop dynamic models for respiratory synctial virus (RSV) transmission and vaccination, to inform target product profiles for RSV vaccine in low-income settings.
I also work on a range of other projects related to estimating the public health impact of the RTS,S/AS01 malaria vaccine and second-generation malaria vaccines in malaria endemic areas.
Before joining the Department of Infectious Disease Epidemiology at Imperial College London, I completed my PhD program at the Research School of Population Health at the Australian National University.
A full list of publications is at www.alexandrahogan.com.
et al., 2022, Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infectious Diseases, ISSN:1473-3099
et al., 2022, Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS, Nature Computational Science, ISSN:2662-8457
et al., 2022, Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic, Communications Medicine, Vol:2, ISSN:2730-664X
et al., 2022, Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia, Scientific Reports, Vol:12, ISSN:2045-2322